Global Greenlight Group: largest international Greenlight experience for benign prostatic hyperplasia to assess efficacy and safety

[1]  A. Frattini,et al.  Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses. , 2020, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

[2]  A. Frattini,et al.  GREEN LIGHT PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE: ONE LASER FOR DIFFERENT PROSTATE SIZES. , 2020, Journal of endourology.

[3]  K. Zorn,et al.  Anatomic GreenLight laser vaporization-incision technique for benign prostatic hyperplasia using the XPS LBO-180W system: How I do it. , 2019, The Canadian journal of urology.

[4]  T. Wilt,et al.  Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019. , 2019, The Journal of urology.

[5]  S. Seery,et al.  Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies , 2019, BMJ Open.

[6]  C. Samama,et al.  Stopping or maintaining oral anticoagulation in patients undergoing photoselective vaporization of the prostate (SOAP) surgery for benign prostate obstruction: study protocol for a multicentre randomized controlled trial , 2018, Trials.

[7]  K. Zorn,et al.  Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update. , 2018, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[8]  H. Woo,et al.  Perioperative adverse events in patients on continued anticoagulation undergoing photoselective vaporisation of the prostate with the 180‐W Greenlight lithium triborate laser , 2017, BJU international.

[9]  S. Kaplan,et al.  Laser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation. , 2016, Urology.

[10]  Matthew P. Rutman,et al.  Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes. , 2015, The Journal of urology.

[11]  F. Bruyère,et al.  180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. , 2014, European urology.

[12]  E. Vicaut,et al.  Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study. , 2013, European urology.

[13]  M. Elhilali,et al.  Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial. , 2012, The Journal of urology.

[14]  A. Al-Ansari,et al.  GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. , 2010, European urology.

[15]  F. Bruyère,et al.  A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. , 2016, European urology.